Drug Topics July 18, 2024
Brian Nowosielski

Emporos announced a strategic partnership with InterLink AI to help pharmacists streamline tasks and fill more prescriptions.

Combining a point of sale (POS) system with scripClip’s lighted pharmacy will-call system, the newly announced partnership between Emporos and InterLink AI will allow pharmacists to streamline tasks, free up their time around the pharmacy, and—crucially— improve patient care with swift yet valued care and services.

“Our partnership with Emporos reinforces the vision we share: to make the pharmacy experience more efficient and safer, for the health of pharmacies and their patients everywhere,” said Dan Gordon, InterLink AI President and CEO.1 “We are thrilled to provide a solution that maximizes operational efficiency at the point of sale.”

InterLink AI is the creator of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Partnerships, Pharma, Pharma / Biotech, Technology, Trends
New 'how-to guide' for future rapid vaccine development
Medicare prescription drug pricing variance: 5 things to know
Sanofi adds new $600M manufacturing plant
How RFK Jr. could use levers of HHS to shape vaccine and drug outcomes
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article